1. Home
  2. AEHL vs BLRX Comparison

AEHL vs BLRX Comparison

Compare AEHL & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEHL
  • BLRX
  • Stock Information
  • Founded
  • AEHL 1993
  • BLRX 2003
  • Country
  • AEHL China
  • BLRX Israel
  • Employees
  • AEHL N/A
  • BLRX N/A
  • Industry
  • AEHL Building Materials
  • BLRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEHL Industrials
  • BLRX Health Care
  • Exchange
  • AEHL Nasdaq
  • BLRX Nasdaq
  • Market Cap
  • AEHL 17.3M
  • BLRX 17.1M
  • IPO Year
  • AEHL 2007
  • BLRX 2011
  • Fundamental
  • Price
  • AEHL $3.71
  • BLRX N/A
  • Analyst Decision
  • AEHL
  • BLRX Strong Buy
  • Analyst Count
  • AEHL 0
  • BLRX 2
  • Target Price
  • AEHL N/A
  • BLRX $19.00
  • AVG Volume (30 Days)
  • AEHL 318.8K
  • BLRX 52.2K
  • Earning Date
  • AEHL 09-25-2025
  • BLRX 11-24-2025
  • Dividend Yield
  • AEHL N/A
  • BLRX N/A
  • EPS Growth
  • AEHL N/A
  • BLRX N/A
  • EPS
  • AEHL N/A
  • BLRX N/A
  • Revenue
  • AEHL $98,773,000.00
  • BLRX $17,251,000.00
  • Revenue This Year
  • AEHL N/A
  • BLRX N/A
  • Revenue Next Year
  • AEHL N/A
  • BLRX N/A
  • P/E Ratio
  • AEHL N/A
  • BLRX N/A
  • Revenue Growth
  • AEHL 36.99
  • BLRX 1.19
  • 52 Week Low
  • AEHL $1.79
  • BLRX $2.30
  • 52 Week High
  • AEHL $32.80
  • BLRX $22.60
  • Technical
  • Relative Strength Index (RSI)
  • AEHL 51.57
  • BLRX 69.50
  • Support Level
  • AEHL $3.32
  • BLRX $3.57
  • Resistance Level
  • AEHL $3.60
  • BLRX $4.56
  • Average True Range (ATR)
  • AEHL 0.31
  • BLRX 0.27
  • MACD
  • AEHL 0.02
  • BLRX 0.08
  • Stochastic Oscillator
  • AEHL 65.02
  • BLRX 87.13

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: